aa 861 has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone: structure given in first source
docebenone : A member of the class of benzoquinones that is p-benzoquinone in which the hydrogens are substituted by three methyl groups and a 12-hydroxydodeca-5,10-diyn-1-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, T | 1 |
| Shiraishi, T | 1 |
| Horinaka, M | 1 |
| Nakata, S | 1 |
| Yasuda, T | 1 |
| Goda, AE | 1 |
| Wakada, M | 1 |
| Mizutani, Y | 1 |
| Miki, T | 1 |
| Nishikawa, A | 1 |
| Sakai, T | 1 |
1 other study available for aa 861 and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Cell Line, Tumor; Down-Regulation; Drug Syn | 2007 |